Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NRC HealthNRC -0.98%63 EV-to-EBIT is 37.56 as of Aug. 15, 2026, which is 52% above its 10-year median of 24.75. GuruFocus rates NRC with a GF Score™ of 63/100 and a GF Value™ of $19.94 (Fairly Valued). The stock has 8 warning signs investors should review. Among 472 Healthcare Providers & Services companies, NRC Health ranks worse than 83.47% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
NRC Health's Enterprise Value for the quarter that ended in Jun. 2026 was $564.2 Mil.
NRC Health's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $14.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NRC Health EV-to-EBIT Related Terms
NRC Health EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for NRC Health's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, NRC Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NRC Health EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NRC Health's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where NRC Health's EV-to-EBIT falls into.
NRC Health's current Enterprise Value is $555.5 Mil.
NRC Health's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $14.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NRC Health (NRC) has a EV-to-EBIT of 37.56 as of Aug. 15, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on NRC Health and its competitors. This is 52% above median its historical median of 24.75. Over the past decade, NRC Health's EV-to-EBIT has ranged from 8.68 to 43.23. According to the industry distribution chart, NRC Health ranks #394 out of 472 companies in the Healthcare Providers & Services industry, placing it in the top 83.5%.
Is NRC Health's EV-to-EBIT too high?
NRC Health's current EV-to-EBIT of 37.56 is 52% above median its 10-year median of 24.75. Over the past 10 years, this metric has ranged from a low of 8.68 to a high of 43.23. The Healthcare Providers & Services industry median EV-to-EBIT is 15.72. NRC Health's value of 37.56 is 139% above this industry median. Based on the distribution chart, NRC Health ranks #394 out of 472 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, NRC Health has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does NRC Health's EV-to-EBIT compare to EVH and SOPH?
According to the Healthcare Providers & Services industry distribution chart, NRC Health ranks #394 out of 472 companies for EV-to-EBIT. This places NRC Health in the lower half of its industry. The industry median EV-to-EBIT is 15.72. NRC Health's value of 37.56 is 139% above this benchmark. Historically, NRC Health's own EV-to-EBIT has ranged from 8.68 to 43.23 over the past decade. While the company's 10-year median is 24.75 vs. the industry median of 15.72, NRC Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.72, based on 472 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NRC Health's current EV-to-EBIT of 37.56 is 139% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on NRC Health and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NRC Health's current EV-to-EBIT is 37.56, which is 52% above median its own 10-year median of 24.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NRC Health stock overvalued right now?
Based on GuruFocus' analysis, NRC Health (NRC) is currently considered Fairly Valued. The stock's GF Value™ is $19.94, compared to a current price of $21.20 — trading 6.3% above its estimated fair value. The current EV-to-EBIT is 37.56, which is 52% above median its 10-year median of 24.75 and 139% above the Healthcare Providers & Services industry median of 15.72. NRC Health's overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For NRC Health (NRC), the current EV-to-EBIT is 37.56 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NRC Health (NRC) Overvalued in 2026?
Based on GuruFocus' analysis, NRC Health stock appears to be overvalued.
The current stock price of $21.20 is trading 6.3% above its estimated GF Value™ of $19.94.
GuruFocus considers NRC Health to be Fairly Valued.
Key valuation signals for NRC:
EV-to-EBIT: 37.56 (52% above median its 10-year median of 24.75)
GF Value™: $19.94 vs. price of $21.20 (6.3% above fair value)
Industry Position: 139% above the Healthcare Providers & Services median (#394 of 472)
No single metric tells the full story. See the NRC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NRC Health operates as a humanized healthcare and support organization. Its platform includes Listen, Understand, and Improve. The group provides solutions for Patient, Consumer, Employee, and Market experiences. The group's commitment to Human Understanding helps healthcare systems get to know the patients, families, consumers, employees, and communities it on a human level.
63GF Score
Get the complete analysis for NRC
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NRC has been successfully added to your 
